Related Experiment Video
Updated: Jun 21, 2026

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
Published on: November 2, 2014
Unusual recurrence in advanced ovarian cancer after interval cytoreductive surgery and HIPEC
Shipra Sonkusare1,2, Somashekhar Sampige Prasannakumar3, Vijay Ahuja4
1Gynaecological Oncology, Aster Hospitals Inc, Bangalore, Karnataka, India sonkusare.shipra8@gmail.com.
Abstract:
Ovarian cancer is the second most fatal gynaecological malignancy. The relapses after treatment of ovarian cancer usually occur within 2 years after completion of the first-line therapy. Recurrent ovarian cancer commonly presents as peritoneal surface deposits in the abdomen with or without ascites. A delayed relapse presenting as a solitary lesion in the urinary bladder wall is unusual in patients treated for advanced ovarian cancer. We report the successful management of a case of solitary metastasis of ovarian cancer in the urinary bladder wall, which occurred more than 6 years after achieving a complete remission state.

